Efficacy and tolerability of lisdexamfetamine dimesylate in children with attention-deficit/hyperactivity disorder: sex and age effects and effect size across the day

• Váldodahkkit: Childress Ann C (Dahkki), Kollins Scott H (Dahkki), Wigal Sharon B (Dahkki), Adeyi Ben (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: BMC, 2010-12-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

<p>Abstract</p> <p>Background</p> <p>Efficacy and safety profiles by sex and age (6-9 vs 10-12 years) and magnitude and duration of effect by effect size overall and across the day of lisdexamfetamine dimesylate (LDX) vs placebo were assessed.</p> <p>Methods...